The effects of a dual orexin receptor antagonist on fear extinction memory and sleep in mice: Implications for exposure therapy
Behavioural Brain Research · 2024
DOI: 10.1016/j.bbr.2023.114741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2024. Verfasst von Ihori Kobayashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Howard University College of Medicine, 520 W St. NW, Washington, DC 20059, USA. Electronic address: ihori.kobayashi@gmail.com. Hauptthemen laut MEDLINE: Orexin Receptor Antagonists, Implosive Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Extinction of conditioned fear is considered a fundamental process in the recovery from posttraumatic stress disorder and anxiety disorders. Sleep, especially rapid-eye-movement (REM) sleep, has been implicated in promoting extinction memory. The orexin system contributes to the regulation of sleep and wakefulness and emotional behaviors. In rodents, administrations of an orexin receptor antagonist following fear extinction training enhanced consolidation of extinction memory. Although orexin antagonists increase sleep, including REM sleep, the possible contribution of sleep to the effects of orexin antagonists on extinction memory has not been examined. Therefore, this study examined the effects of suvorexant, a dual orexin receptor antagonist, on extinction memory and sleep and their associations in mice. C57BL/6 mice underwent sleep recording for 24 h before and after contextual fear conditioning with footshocks and extinction learning during the early light phase or early dark phase. Mice were systemically injected with either 25 mg/kg of suvorexant or vehicle immediately after the extinction session. We found that suvorexant neither altered sleep nor improved extinction memory recall compared with vehicle. The higher percentages of REM sleep during the post-extinction dark phase were associated with lower extinction memory recall and greater freezing responses to the fear context. Results also indicate that animals did not reach complete extinction of fear with the fear extinction training protocol used in this study. These findings suggest that promoting REM sleep may not enhance fear extinction memory when extinction of fear is incomplete.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Howard University College of Medicine, 520 W St. NW, Washington, DC 20059, USA. Electronic address: ihori.kobayashi@gmail.com.
- Georgetown University School of Medicine, 3970 Reservoir Rd NW, Washington, DC 20007, USA.
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
- National Institutes of Health
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Kobayashi, I., & Forcelli, P. A. (2024). The effects of a dual orexin receptor antagonist on fear extinction memory and sleep in mice: Implications for exposure therapy. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114741
Vancouver
Kobayashi I, Forcelli PA. The effects of a dual orexin receptor antagonist on fear extinction memory and sleep in mice: Implications for exposure therapy. Behavioural Brain Research. 2024. doi:10.1016/j.bbr.2023.114741
BibTeX
@article{Kobayashi2024,
author = {Kobayashi, Ihori and Forcelli, Patrick A},
title = {The effects of a dual orexin receptor antagonist on fear extinction memory and sleep in mice: Implications for exposure therapy},
journal = {Behavioural Brain Research},
year = {2024},
doi = {10.1016/j.bbr.2023.114741}
}
EUVIMED